A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
about
A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A new endoscopically implantab ...... ose, insulin, and GLP-1 levels
@en
type
label
A new endoscopically implantab ...... ose, insulin, and GLP-1 levels
@en
prefLabel
A new endoscopically implantab ...... ose, insulin, and GLP-1 levels
@en
P2093
P1433
P1476
A new endoscopically implantab ...... ose, insulin, and GLP-1 levels
@en
P2093
Franziska Reining
Guido Schachschal
Jennifer Pezold
Jens Aberle
Nina Sauer
Oliver Mann
Stefan Groth
Thomas Rösch
P2888
P304
P356
10.1007/S11695-013-1005-0
P50
P577
2013-11-01T00:00:00Z